# FDA Inspection 1200649 - ImpactLife - March 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/impactlife/35e09b68-ba57-41b5-be76-5e429f2c29e5
Source feed: FDA_Inspections

> FDA Inspection 1200649 for ImpactLife on March 22, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200649
- Company Name: ImpactLife
- Inspection Date: 2023-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200649 - 2023-03-22](https://www.keypedia.com/records/fda_inspections/impactlife/e23090b4-251b-4b01-94e9-bad8cba6a131)
- [FDA Inspection 1071315 - 2018-11-07](https://www.keypedia.com/records/fda_inspections/impactlife/0cbe91b6-cb48-444b-8d46-52395a92ca2d)
- [FDA Inspection 988976 - 2016-10-19](https://www.keypedia.com/records/fda_inspections/impactlife/b57ac728-85a1-4aba-b479-4d86866e1d84)
- [FDA Inspection 903079 - 2014-10-22](https://www.keypedia.com/records/fda_inspections/impactlife/11609710-8131-477d-b336-269a144de6a5)
- [FDA Inspection 802809 - 2012-10-10](https://www.keypedia.com/records/fda_inspections/impactlife/9dc6a7e0-0801-48b9-879a-91dbd633964e)

Company: https://www.keypedia.com/companies/impactlife/060b4e2f-b09c-4a5f-a216-5c025f6231fe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d